These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15451454)

  • 1. Identification of pretreatment agents to enhance adenovirus infection of bladder epithelium.
    Ramesh N; Memarzadeh B; Ge Y; Frey D; VanRoey M; Rojas V; Yu DC
    Mol Ther; 2004 Oct; 10(4):697-705. PubMed ID: 15451454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of pretreatment agents to enhance adenovirus infection of bladder epithelium.
    Ratliff TL
    J Urol; 2005 Jun; 173(6):2198-9. PubMed ID: 15879887
    [No Abstract]   [Full Text] [Related]  

  • 3. A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium.
    Lin LF; Zhu G; Yoo JJ; Soker S; Sukhatme VP; Atala A
    J Urol; 2002 Aug; 168(2):813-8. PubMed ID: 12131373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of polyamides that enhance adenovirus-mediated gene expression in the urothelium.
    Connor RJ; Engler H; Machemer T; Philopena JM; Horn MT; Sutjipto S; Maneval DC; Youngster S; Chan TM; Bausch J; McAuliffe JP; Hindsgaul O; Nagabhushan TL
    Gene Ther; 2001 Jan; 8(1):41-8. PubMed ID: 11402300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo.
    Chester JD; Kennedy W; Hall GD; Selby PJ; Knowles MA
    Gene Ther; 2003 Jan; 10(2):172-9. PubMed ID: 12571646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model.
    Siemens DR; Crist S; Austin JC; Tartaglia J; Ratliff T
    J Urol; 2003 Sep; 170(3):979-84. PubMed ID: 12913754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
    Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
    Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer.
    Yamashita M; Rosser CJ; Zhou JH; Zhang XQ; Connor RJ; Engler H; Maneval DC; Karashima T; Czerniak BA; Dinney CP; Benedict WF
    Cancer Gene Ther; 2002 Aug; 9(8):687-91. PubMed ID: 12136430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the glycosaminoglycan layer on the permeation of hypericin in rat bladders in vivo.
    Huygens A; Crnolatac I; Maes J; Van Cleynenbreugel B; Van Poppel H; Roskams T; de Witte PA
    BJU Int; 2007 Nov; 100(5):1176-81. PubMed ID: 17868424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium.
    Siemens DR; Austin JC; See WA; Tartaglia J; Ratliff TL
    J Urol; 2001 Feb; 165(2):667-71. PubMed ID: 11176455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
    Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF
    Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
    Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
    J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simplified system for generating oncolytic adenovirus vector carrying one or two transgenes.
    Hu ZB; Wu CT; Wang H; Zhang QW; Wang L; Wang RL; Lu ZZ; Wang LS
    Cancer Gene Ther; 2008 Mar; 15(3):173-82. PubMed ID: 18157145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An ex vivo human model system to evaluate specificity of replicating and non-replicating gene therapy agents.
    Rots MG; Elferink MG; Gommans WM; Oosterhuis D; Schalk JA; Curiel DT; Olinga P; Haisma HJ; Groothuis GM
    J Gene Med; 2006 Jan; 8(1):35-41. PubMed ID: 16044485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor effect of oncolytic adenovirus expressing interleukin-12 and B7-1 in an immunocompetent murine model.
    Lee YS; Kim JH; Choi KJ; Choi IK; Kim H; Cho S; Cho BC; Yun CO
    Clin Cancer Res; 2006 Oct; 12(19):5859-68. PubMed ID: 17020994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.
    Okegawa T; Nutahara K; Pong RC; Higashihara E; Hsieh JT
    J Urol; 2005 Aug; 174(2):747-52. PubMed ID: 16006969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient gene transfer into murine pancreatic islets using adenovirus vectors.
    Mukai E; Fujimoto S; Sakurai F; Kawabata K; Yamashita M; Inagaki N; Mizuguchi H
    J Control Release; 2007 May; 119(1):136-41. PubMed ID: 17331612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of transduction efficiency using Adeno-associated viral vectors by chemical pretreatment to mice bladder urothelium.
    Hamada A; Kita Y; Murakami K; Matsumoto K; Sakatani T; Sano T; Ogawa O; Kobayashi T
    J Virol Methods; 2020 May; 279():113854. PubMed ID: 32198026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the MB49 mouse bladder cancer model for adenoviral gene therapy.
    Loskog A; Ninalga C; Hedlund T; Alimohammadi M; Malmström PU; Tötterman TH
    Lab Anim; 2005 Oct; 39(4):384-93. PubMed ID: 16197705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.